Does Cinnamon Cognition Randomized Trial work?

Updated July 2026

Quick Answer

Cinnamon Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Symptoms of Long COVID include the onset of new psychiatric problems including increased anxiety and depression, cognitive impairment, often referred to as “brain fog”, as well as sleep dysfunction and daytime fatigue [,,,,,,].

Key Takeaways

  • 01Symptoms of Long COVID include the onset of new psychiatric problems including increased anxiety and depression, cognitive impairment, often referred to as “brain fog”, as well as sleep dysfunction and daytime fatigue [,,,,,,]. [Cash Nicole (2026)]
  • 02[44] [45] [46] 47 47 Trigeminal nerve stimulation (TNS) is a novel, non-invasive, pain-free, method of neuromodulation currently being used to reduce symptoms associated with a wide range of neuropsychiatric conditions including disturbances in mood, sleep, and cognition [,,]. [Cash Nicole (2026)]
  • 03Our findings indicated that a single, 30-min session of active TNS, compared to sham TNS, significantly improved the ability to detect odors for up to 30 min. [Cash Nicole (2026)]
  • 04Reportedly, as high as 54 % of people recovered from the initial infection endorse at least 1 long-term (>6 month from diagnosis) symptom of Long COVID []. [Cash Nicole (2026)]
The current Migaku evidence database contains 2 reusable source documents for Cinnamon Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Symptoms of Long COVID include the onset of new psychiatric problems including increased anxiety and depression, cognitive impairment, often referred to as “brain fog”, as well as sleep dysfunction and daytime fatigue [,,,,,,]. [Cash Nicole (2026); evidence level 2] - [44] [45] [46] 47 47 Trigeminal nerve stimulation (TNS) is a novel, non-invasive, pain-free, method of neuromodulation currently being used to reduce symptoms associated with a wide range of neuropsychiatric conditions including disturbances in mood, sleep, and cognition [,,]. [Cash Nicole (2026); evidence level 2] - Our findings indicated that a single, 30-min session of active TNS, compared to sham TNS, significantly improved the ability to detect odors for up to 30 min. [Cash Nicole (2026); evidence level 2] - Reportedly, as high as 54 % of people recovered from the initial infection endorse at least 1 long-term (>6 month from diagnosis) symptom of Long COVID []. [Cash Nicole (2026); evidence level 2] - A growing body of evidence supports the therapeutic potential of volatile terpenes such as limonene (from citrus) and pinene (from pine and sage), which have been specifically studied for their anti-inflammatory, antioxidant, and neuroprotective activities [–]. [Kim Jenny Ji Hyun (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Study of Chemosensory Enhancement through Neuromodulation Training (SCENT): Design and methodology of a randomized clinical trial for COVID-related persistent smell dysfunction ☆
  2. Harnessing phytochemicals for engineering health solutions